After a strong start to the year, this month saw bigger and more consistent checks flowing into healthtech.
January and February had standout deals, but funding was more uneven—peaking with a few large rounds and tapering quickly.
In contrast, March delivered multiple $200 Mn+ raises alongside a solid mid-stage pipeline, signaling stronger conviction from investors.
We also noticed:
- Capital flowing towards execution
- AI becoming operational infrastructure across healthcare—running workflows, governing systems, and even stepping into clinical decision-making
- Mental health seeing sustained backing, while neurotech and deep tech players edge closer to real-world deployment.
If the first two months showed momentum, March funding announcements show direction, from tools to full-stack platforms, from pilots to scaled deployment and from cautious bets to high-conviction capital.
Here’s a look at who raised what:
1) Verily (now Verily Health Inc.)
Funds raised: $300 Mn
Funding Round: Series E
Investors: Series X Capital (lead), Alphabet, UCHealth, University of Colorado Anschutz
About: Verily (Google’s life sciences arm) sits at the intersection of data, AI, and life sciences, building precision health platforms to improve disease prevention, diagnosis, and care delivery.
How do they plan to use the funds: To scale its AI-driven precision health platform, unify healthcare data, expand partnerships, and deploy AI insights into clinical research and care workflows.
2) Science Corporation
Funds raised: $230 Mn
Funding Round: Series C
Investors: Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT, Quiet Capital
About: A neural engineering company building brain-computer interface (BCI) and retinal implant technologies to restore vision and treat neurological conditions.
How do they plan to use the funds: To commercialize its PRIMA retinal implant, expand clinical trials for additional eye diseases, and scale research and manufacturing infrastructure.
3) eMed
Funds raised: $200 Mn
Funding Round: Series A
Investors: Aon Consulting (lead), with participation from Tom Brady, Jeff Aronin, Joe Lonsdale, Antonio Gracias, Linda Yaccarino and others
About: A digital health and telehealth platform focused on population health management, including clinically guided programs for GLP-1 drugs (obesity and diabetes), along with at-home diagnostics.
How do they plan to use the funds: To advance its AI-driven platform, support a new healthcare payment model for employers, and scale programs aimed at reducing healthcare costs.
4) Grow Therapy
Funds raised: $150 Mn
Funding Round: Series D
Investors: TCV, Goldman Sachs Alternatives (Growth Equity) (co-leads), with participation from BCI, Menlo Ventures, Sequoia, SignalFire, Transformation Capital
About: A mental health platform that connects patients with therapists and psychiatrists covered by insurance, enabling both in-person and virtual care.
How do they plan to use the funds: To expand partnerships with health plans, employers, and health systems, and improve access and outcomes in mental healthcare.
5) Qualified Health
Funds raised: $125 Mn
Funding Round: Series B
Investors: New Enterprise Associates (lead), Transformation Capital, GreatPoint Ventures, Cathay Innovation, Anthology Fund (Menlo Ventures + Anthropic), along with existing investors like SignalFire and Flare Capital
About: A healthcare AI infrastructure platform that helps health systems evaluate, deploy, and govern AI tools across clinical and operational workflows.
How do they plan to use the funds: To scale its enterprise AI platform, expand across U.S. health systems, and invest in product development and engineering.
6) Cognito Therapeutics
Funds raised: $105 Mn
Funding Round: Series C
Investors: Morningside Ventures, IAG Capital Partners, Starbloom Capital (co-leads), with participation from New Vintage, Apollo Health Ventures, Benvolio Group
About: A neurotechnology company developing non-invasive therapies for Alzheimer’s using light and sound stimulation to restore brain activity and slow cognitive decline.
How do they plan to use the funds: To advance clinical trials, support regulatory submission, and prepare for commercialization of its Alzheimer’s treatment device (Spectris).
7) Latent Health
Funds raised: $80 Mn
Funding Round: Series A
Investors: Spark Capital, Transformation Capital (co-leads), with participation from General Catalyst, McKesson Ventures, Y Combinator, Conviction
About: A clinical AI company that automates medication access workflows using AI to process patient data, interpret drug criteria, and speed up approvals between providers, payers, and pharmacies.
How do they plan to use the funds: To expand its platform, grow partnerships with health systems, scale its team, and deepen integrations across the medication access workflow.
8) Adonis
Funds raised: $40 Mn
Funding Round: Series C
Investors: Quadrille Capital (lead), with participation from General Catalyst and Bling Capital
About: An AI-driven revenue cycle management platform that helps healthcare providers identify, manage, and resolve billing and claims issues to improve reimbursements.
How do they plan to use the funds: To accelerate product innovation (AI agents + orchestration platform), expand across health systems, and grow its team.
9) Doctronic
Funds raised: $40 Mn
Funding Round: Series B
Investors: Abstract, Lightspeed Venture Partners (co-leads), Seven Stars, Union Square Ventures, Tusk Ventures, Mantis
About: An AI-powered “doctor” platform offering 24/7 consultations that can autonomously assess symptoms, provide medical guidance, and connect patients to licensed physicians.
How do they plan to use the funds: To expand into pediatrics, scale partnerships with health systems and payers, and grow its AI-driven care infrastructure.
10) Plum (Plum Benefits)
Funds raised: ~$20.5 Mn
Funding Round: Series B
Investors: Peak XV Partners (lead), Tanglin Venture Partners, GMO Venture Partners
About: A Bengaluru-based employee health benefits platform offering group insurance along with healthcare services like telehealth, wellness programs, and AI-driven claims management.
How do they plan to use the funds: To strengthen AI-driven claims processing, expand healthcare offerings (preventive, primary care, mental health), deepen HR/payroll integrations, and scale reach across enterprises.
11) Parallel Health
Funds raised: $20 Mn
Funding Round: Series A
Investors: Index Ventures (lead), Frst, Y Combinator, Hexa, and angel investors including Arthur Mensch, Felix Blossier, Quentin de Metz
About: A Paris-based startup building AI agents that automate hospital administrative workflows like medical coding, billing, and admissions by operating directly on top of existing hospital software.
How do they plan to use the funds: To scale deployment of its AI agents, expand internationally, develop new automation solutions for hospital workflows, and grow its team.
12) Blossom Health
Funds raised: $20 Mn
Funding Round: Seed + Series A
Investors: Headline (lead), Village Global, TA Ventures, Operator Partners, Correlation Ventures, angel investors
About: An AI-native psychiatry platform that combines clinical copilots and AI agents to support psychiatrists with diagnosis, treatment decisions, and continuous patient engagement.
How do they plan to use the funds: To expand across more U.S. states, onboard more clinicians, deepen payer partnerships, and advance its AI technology.
Wrapping up
Three signals standing out from March healthtech funding roundup:
- AI is becoming infrastructure, not a feature
- Larger checks are clustering around fewer, more mature players
- Deep tech is getting closer to commercialization, not just research
Compared to January and February, where momentum was broad but uneven, March feels more decisive. Capital is concentrating around companies that can deliver measurable efficiency, scale across systems, and take ownership of critical workflows.
Source: HealthTech Alpha’s funding data
We’re the exclusive HealthTech Alpha partners in India! Reach out if you’re looking for deeper market intelligence or strategic perspectives.
